Transforming the treatment of inherited arrhythmias and cardiometabolic diseases.
Montreal, Quebec
Thryv Therapeutics Inc. is a clinical-stage biotech pioneering precision medicine approaches to treating genetic arrhythmia syndromes and acquired cardiometabolic diseases through potent and highly selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1). For more information, please visit www.thryvtrx.com.
On-site · Montréal
Perform biochemical and cellular assays, compound screening, potency testing, and routine mammalian cell culture to support drug discovery and structure-activity relationship research. Maintain accurate laboratory records, monitor assay and cell quality, manage supplies and equipment, and follow laboratory safety and operational procedures.
On-site · Montréal
Perform biochemical and cellular assays, compound screening, and mammalian cell culture to support efficacy testing and structure-activity relationship studies. Prepare experimental materials, document work, monitor assay and cell quality, maintain laboratory inventory and equipment, and follow safety and data-integrity requirements.